Lloyd Price

MARCH 3, 2024

Exec Summary: The future of mental health chatbots is likely to be one of cautious optimism. The ultimate goal should be to leverage these tools responsibly and ethically to complement, not replace, human connection and professional mental health care.

Mental health 64

Mental health healthcare technology Leadership Digital Health 64

Lloyd Price

FEBRUARY 18, 2024

Specific Topics: Emerging technologies: Blockchain, AR/VR, and the metaverse in healthcare. Mental health and digital therapeutics. The role of social determinants of health in digital health interventions. Policy and regulatory landscape for digital health.

Digital Health 58

Digital Health Leadership healthcare technology Healthcare Innovation 58

Lloyd Price

APRIL 9, 2024

Health Equity in Digital Health: How can we ensure everyone has fair and just access to digital health tools? Digital Mental Health: With rising mental health concerns, discussions around telehealth, remote monitoring, and mental health apps are likely to be prominent.

Digital Health 61

Digital Health Mental health healthcare technology Leadership 61

Lloyd Price

MARCH 24, 2024

chronic disease management, mental health) are more valuable due to their established customer loyalty and potential for growth. Investment climate: The overall health of the investment climate and investor appetite for healthcare technology can significantly impact M&A valuations. times and 3.1

healthcare technology 61

healthcare technology Leadership Telehealth Telemedicine 61

Lloyd Price

DECEMBER 7, 2023

Merck Ventures: Merck Ventures has invested in a range of healthtech startups, including Clue, GlycoMimetics, and AbCellera, demonstrating its interest in areas such as women's health, oncology, and immunotherapy. In 2022, Denali Therapeutics partnered with Pfizer to develop a potential treatment for Alzheimer's disease.

Digital Health 67

Digital Health Mental health healthcare technology Leadership 67

Lloyd Price

NOVEMBER 25, 2023

These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.

Pharmaceuticals 64

Pharmaceuticals Pain management Chronic pain management Mental health 64

Healthcare IT Today

JANUARY 18, 2024

Grace Nam, Strategic Solutions Manager at Laserfiche Trends in healthcare technology in 2024 will heavily focus on cost-effective solutions to drive operational efficiency and increase workforce satisfaction for physicians and staff. Employers and insurers will offer incentives for employees to use these technologies.

Health IT 74

Health IT Primary Care Digital Health Mental health 74